AVALON GLOBOCARE CORP (ALBT) Fundamental Analysis & Valuation

NASDAQ:ALBT • US05344R3021

0.8787 USD
-0.04 (-4.17%)
At close: Mar 9, 2026
0.83 USD
-0.05 (-5.54%)
After Hours: 3/9/2026, 8:00:01 PM
Overview Stock Chart Technical Analysis Fundamental Analysis Forecast Earnings Financials Ownership News

This ALBT fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

Fundamental Rating

1

ALBT gets a fundamental rating of 1 out of 10. The analysis compared the fundamentals against 62 industry peers in the Real Estate Management & Development industry. ALBT has a bad profitability rating. Also its financial health evaluation is rather negative. ALBT is valued expensive and it does not seem to be growing.


Dividend Valuation Growth Profitability Health

0

1. ALBT Profitability Analysis

1.1 Basic Checks

  • ALBT had negative earnings in the past year.
  • ALBT had a negative operating cash flow in the past year.
  • In the past 5 years ALBT always reported negative net income.
  • ALBT had a negative operating cash flow in each of the past 5 years.
ALBT Yearly Net Income VS EBIT VS OCF VS FCFALBT Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -5M -10M -15M

1.2 Ratios

  • ALBT has a worse Return On Assets (-205.48%) than 90.32% of its industry peers.
Industry RankSector Rank
ROA -205.48%
ROE N/A
ROIC N/A
ROA(3y)-59.75%
ROA(5y)-78.06%
ROE(3y)-148.3%
ROE(5y)-209.56%
ROIC(3y)N/A
ROIC(5y)N/A
ALBT Yearly ROA, ROE, ROICALBT Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -100 -200 -300 -400

1.3 Margins

  • ALBT's Gross Margin of 25.69% is in line compared to the rest of the industry. ALBT outperforms 53.23% of its industry peers.
  • ALBT's Gross Margin has declined in the last couple of years.
  • ALBT does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 25.69%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-19.46%
GM growth 5Y-6.82%
ALBT Yearly Profit, Operating, Gross MarginsALBT Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -500 -1K

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

1

2. ALBT Health Analysis

2.1 Basic Checks

  • ALBT does not have a ROIC to compare to the WACC, probably because it is not profitable.
  • ALBT has more shares outstanding than it did 1 year ago.
  • ALBT has less shares outstanding than it did 5 years ago.
  • Compared to 1 year ago, ALBT has an improved debt to assets ratio.
ALBT Yearly Shares OutstandingALBT Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 2M 4M 6M 8M
ALBT Yearly Total Debt VS Total AssetsALBT Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 5M 10M 15M 20M

2.2 Solvency

  • Based on the Altman-Z score of -19.65, we must say that ALBT is in the distress zone and has some risk of bankruptcy.
  • ALBT's Altman-Z score of -19.65 is on the low side compared to the rest of the industry. ALBT is outperformed by 85.48% of its industry peers.
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Altman-Z -19.65
ROIC/WACCN/A
WACC11.72%
ALBT Yearly LT Debt VS Equity VS FCFALBT Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 5M -5M 10M

2.3 Liquidity

  • ALBT has a Current Ratio of 0.15. This is a bad value and indicates that ALBT is not financially healthy enough and could expect problems in meeting its short term obligations.
  • With a Current ratio value of 0.15, ALBT is not doing good in the industry: 90.32% of the companies in the same industry are doing better.
  • ALBT has a Quick Ratio of 0.15. This is a bad value and indicates that ALBT is not financially healthy enough and could expect problems in meeting its short term obligations.
  • ALBT's Quick ratio of 0.15 is on the low side compared to the rest of the industry. ALBT is outperformed by 90.32% of its industry peers.
Industry RankSector Rank
Current Ratio 0.15
Quick Ratio 0.15
ALBT Yearly Current Assets VS Current LiabilitesALBT Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 2M 4M 6M 8M 10M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

1

3. ALBT Growth Analysis

3.1 Past

  • The Earnings Per Share has grown by an impressive 50.14% over the past year.
  • ALBT shows a small growth in Revenue. In the last year, the Revenue has grown by 6.65%.
  • Measured over the past years, ALBT shows a decrease in Revenue. The Revenue has been decreasing by -2.97% on average per year.
EPS 1Y (TTM)50.14%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%96.56%
Revenue 1Y (TTM)6.65%
Revenue growth 3Y-1.38%
Revenue growth 5Y-2.97%
Sales Q2Q%1.42%

3.2 Future

  • No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

  • No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
ALBT Yearly Revenue VS EstimatesALBT Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2016 2017 2018 2019 2020 2021 2022 2023 2024 500K 1M 1.5M

More info and screens

Find the best growth stocksShow best growing peers

0

4. ALBT Valuation Analysis

4.1 Price/Earnings Ratio

  • ALBT reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
ALBT Price Earnings VS Forward Price EarningsALBT Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0 0 0 0 0 0 0

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
ALBT Per share dataALBT EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 -2 -4 -6 -8

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. ALBT Dividend Analysis

5.1 Amount

  • ALBT does not give a dividend.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

Find the best dividend stocksShow peers with best dividend

ALBT Fundamentals: All Metrics, Ratios and Statistics

AVALON GLOBOCARE CORP

NASDAQ:ALBT (3/9/2026, 8:00:01 PM)

After market: 0.83 -0.05 (-5.54%)

0.8787

-0.04 (-4.17%)

Chartmill FA Rating
GICS SectorReal Estate
GICS IndustryGroupEquity Real Estate Investment Trusts (REITs)
GICS IndustryReal Estate Management & Development
Earnings (Last)11-13
Earnings (Next)03-30
Inst Owners1.78%
Inst Owner Change113.08%
Ins Owners6.55%
Ins Owner ChangeN/A
Market Cap5.06M
Revenue(TTM)1.40M
Net Income(TTM)-18.76M
AnalystsN/A
Price TargetN/A
Short Float %3.44%
Short Ratio0.02
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 3.63
P/FCF N/A
P/OCF N/A
P/B N/A
P/tB N/A
EV/EBITDA N/A
EPS(TTM)-9.75
EYN/A
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)-0.96
FCFYN/A
OCF(TTM)-0.95
OCFYN/A
SpS0.24
BVpS-0.78
TBVpS-0.78
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -205.48%
ROE N/A
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 25.69%
FCFM N/A
ROA(3y)-59.75%
ROA(5y)-78.06%
ROE(3y)-148.3%
ROE(5y)-209.56%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-19.46%
GM growth 5Y-6.82%
F-Score5
Asset Turnover0.15
Health
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 0.15
Quick Ratio 0.15
Altman-Z -19.65
F-Score5
WACC11.72%
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)50.14%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%96.56%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)6.65%
Revenue growth 3Y-1.38%
Revenue growth 5Y-2.97%
Sales Q2Q%1.42%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-89.27%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y28.54%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y28.82%
OCF growth 3YN/A
OCF growth 5YN/A

AVALON GLOBOCARE CORP / ALBT FAQ

Can you provide the ChartMill fundamental rating for AVALON GLOBOCARE CORP?

ChartMill assigns a fundamental rating of 1 / 10 to ALBT.


What is the valuation status for ALBT stock?

ChartMill assigns a valuation rating of 0 / 10 to AVALON GLOBOCARE CORP (ALBT). This can be considered as Overvalued.


What is the profitability of ALBT stock?

AVALON GLOBOCARE CORP (ALBT) has a profitability rating of 0 / 10.